Neogen’s earnings report this Thursday could be a turning point: while they beat estimates last quarter with $211.2M in revenue, they’ve struggled to meet targets recently. The market expects a 5.7% year-over-year revenue drop this quarter—similar to last year’s 4.8% decline. Meanwhile, rivals like Abbott and Intuitive Surgical are soaring, with Abbott’s stock up 12% and Intuitive Surgical’s down 14%—highlighting a sector-wide divergence. Neogen’s stock has stayed flat while analysts hold a $12 price target, up from its current $9.15. Can they break the pattern and deliver a win for investors?
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
